Home » Agilent, MRM Proteomics Extend Co-marketing Agreement

Agilent, MRM Proteomics Extend Co-marketing Agreement

Jul 24, 2014
|
staff reporter

NEW YORK (GenomeWeb) – Agilent Technologies today announced the extension of a co-marketing agreement with MRM Proteomics.

The extension expands a deal between the companies reached in September 2012, and will allow the partners to improve their combined proteomics solutions comprising reagents kits, hardware, and software, Agilent said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

What's Popular?

In Proteomics & Protein Research

  1. Fluidigm Completes $30M Equity Offering

  2. PNNL Team Releases Software Package for Top-Down Proteomics

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.